MarketPeel
Insider Trading Intelligence
Pricing
…
TS

Thomas J. Schuetz

CMPX
CHIEF EXECUTIVE OFFICER · COMPASS THERAPEUTICS, INC. · CIK 0001591464
FILING MIX · LIFETIME72%/28%
BUYS
33
SELLS
13
TOTAL VALUE
$10.16M
COMPANIES
2
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
6,603,336
AVG SELL PX
$15.94
TRADE KIND
SHOWING 46 / 46
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
22 backtested trades · 8 horizons · 1 pending
Forward-return performance of every backtestable P/S trade by Thomas J. Schuetz, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d22+63.64%+7.30%+0.38%+6.92%+1.83%—
14d22+54.55%+7.92%-0.79%+8.71%+1.50%—
30d22+59.09%+7.27%-1.75%+9.02%+6.93%—
60d22+59.09%+15.23%+1.25%+13.97%-0.20%—
90d22+77.27%+30.56%+2.50%+28.06%+19.09%—
180d22+77.27%+42.74%+4.72%+38.02%+46.04%—
1y22+54.55%-3.47%+15.27%-18.74%-13.01%—
2y22(1 pending)+0.00%-39.09%+44.39%-83.48%-84.55%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CMPX · 6,603,336 shares · as of Feb 8, 2026
01,671,7003,343,4005,015,1006,686,800202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 33 buys / 13 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CMPX
COMPASS THERAPEUTICS, INC.
SALE
CHIEF EXECUTIVE OFFICER
36,687$6.52$239.2K6,603,336Feb 8, 2026Feb 10, 2026 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
SALE
CHIEF EXECUTIVE OFFICER
46,777$5.35$250.3K6,640,023Jan 9, 2026Jan 12, 2026 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
250,000$5.17$1.29M6,686,800Jan 2, 2026Jan 5, 2026 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,000,000——2,000,000Jan 2, 2026Jan 5, 2026 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
SALE
CHIEF EXECUTIVE OFFICER
44,025$4.83$212.6K6,436,800Nov 16, 2025Nov 18, 2025 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
10,000$2.11$21.1K6,480,825May 27, 2025May 27, 2025 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,500,000——1,500,000Feb 11, 2025Feb 13, 2025 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
SALE
CEO
41,687$3.50$145.9K6,470,825Feb 8, 2025Feb 11, 2025 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
SALE
CEO
58,054$1.86$108.0K6,512,512Jan 9, 2025Jan 13, 2025 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
SALE
PRESIDENT
44,782$1.45$64.9K6,570,566Feb 8, 2024Feb 9, 2024 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
637,500$1.93$1.23M6,615,348Jan 9, 2024Jan 10, 2024 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
637,500——637,500Jan 9, 2024Jan 10, 2024 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
SALE
CHIEF EXECUTIVE OFFICER
44,025$1.50$66.0K5,977,848Nov 17, 2023Nov 21, 2023 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
10,000$3.37$33.7K6,021,873Mar 10, 2023Mar 10, 2023 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
20,000$3.98$79.6K6,011,873Feb 27, 2023Feb 27, 2023 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
20,000$3.86$77.2K5,991,873Feb 15, 2023Feb 15, 2023 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
500,000——5,971,873Feb 8, 2023Feb 9, 2023 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
700,000——700,000Feb 8, 2023Feb 9, 2023 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
20,000$4.05$81.0K5,471,873Jan 31, 2023Jan 31, 2023 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
20,000$4.19$83.8K5,451,873Jan 24, 2023Jan 24, 2023 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
10,000$2.32$23.2K5,431,873Sep 28, 2022Sep 28, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
15,000$2.27$34.0K5,421,873Sep 26, 2022Sep 27, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
15,000$3.03$45.5K5,406,873Sep 7, 2022Sep 8, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
15,000$2.83$42.5K5,391,873Sep 1, 2022Sep 1, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
15,000$3.05$45.8K5,376,873Aug 17, 2022Aug 17, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
15,000$2.64$39.6K5,361,873Aug 10, 2022Aug 10, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
15,000$2.58$38.7K5,346,873Aug 1, 2022Aug 2, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
20,000$2.80$56.0K5,331,873Jun 21, 2022Jun 21, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
20,000$2.34$46.8K5,311,873Jun 16, 2022Jun 17, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
30,000$2.29$68.7K5,291,873Jun 13, 2022Jun 13, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
30,000$2.83$84.9K5,261,873Jun 6, 2022Jun 7, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
20,000$3.03$60.6K5,231,873Jun 1, 2022Jun 1, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
20,000$3.04$60.8K5,211,873May 26, 2022May 26, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
18,355$2.72$49.9K5,191,873May 23, 2022May 24, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
20,215$2.47$49.9K5,173,518May 17, 2022May 17, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
27,836$1.80$50.1K5,153,303May 10, 2022May 10, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
700,000——700,000Feb 18, 2022Feb 23, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
700,000——700,000Feb 17, 2022Feb 18, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
700,000——700,000Feb 9, 2021Mar 1, 2021 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
250,000——250,000Dec 22, 2020Dec 23, 2020 ↗View →
BOLD
BOUNDLESS BIO, INC.
SALE
89,695$60.00$5.38M0Jan 15, 2020Jan 15, 2020 ↗View →
BOLD
BOUNDLESS BIO, INC.
SALE
5,605——0Jan 15, 2020Jan 15, 2020 ↗View →
BOLD
BOUNDLESS BIO, INC.
SALE
18,086——0Jan 15, 2020Jan 15, 2020 ↗View →
BOLD
BOUNDLESS BIO, INC.
SALE
9,000——0Jan 15, 2020Jan 15, 2020 ↗View →
BOLD
BOUNDLESS BIO, INC.
SALE
16,200——0Jan 15, 2020Jan 15, 2020 ↗View →
BOLD
BOUNDLESS BIO, INC.
SALE
10,000——0Jan 15, 2020Jan 15, 2020 ↗View →
Other insiders · CMPX
Loading peer insiders…
About this filer
CIK 0001591464
ROLE
CHIEF EXECUTIVE OFFICER
PRIMARY
CMPX
COMPANIES
2
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001591464DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback